Avalyn Pharma Inc.

AVLN·NASDAQ·$26.70·$1B

Financials

10-QQuarter ended 06/30/2608/12/2610-QQuarter ended 03/31/2606/03/26

Disclosures

8-KCurrent report09/16/268-KCurrent report08/12/268-KCurrent report07/01/268-KCurrent report06/17/268-KCurrent report06/03/26

Prospectuses and Registrations

424B4Prospectus04/30/26S-8Registration of securities for employees04/30/26S-1/ARegistration statement (amended)04/29/26S-1/ARegistration statement (amended)04/23/26S-1Registration statement (IPO)04/08/26

Proxies

No matching filings.

Ownership

Form 3Initial insider ownership09/17/26Form 4Insider transaction09/17/26SC 13GBeneficial ownership08/14/26SC 13GBeneficial ownership08/11/26SC 13G/ABeneficial ownership (amended)08/06/26

Other

CERTCEO/CFO certification04/29/26EFFECTRequest for effectiveness04/29/268-A12B8-A12B04/27/26DRS/ADRS/A03/18/26DRSDRS02/06/26